65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79726D0087
- Awardee
-
Xeris Pharmaceuticals, Inc. UEI YAV5AK7VKJ31
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 11% complete
- IDV ceiling
- $44,862,427.20
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
Xeris Pharmaceuticals, Inc. (UEI: YAV5AK7VKJ31) has been awarded a multiple award Federal Supply Schedule contract by the Department of Veterans Affairs Veterans Integrated Service Network 12, effective April 1, 2026, through March 31, 2031. This civilian agency contract, with a ceiling value of $44.86 million and no set-asides applied, establishes a vehicle for the procurement of drugs, pharmaceuticals, and hematology-related products classified under Federal Supply Classification 65 I B. As a specialty pharmaceutical company and registered small disadvantaged business, Xeris will supply patient-friendly therapeutic medicines to support the Veterans Health Administration's healthcare delivery operations across the designated service network.
Under this Federal Supply Schedule contract, ordering activities within the Department of Veterans Affairs may place orders against established pricing and terms to procure Xeris' pharmaceutical portfolio for veteran healthcare needs. The contract builds upon Xeris' demonstrated performance under previous supply schedules with the same agency, including prior agreements for products such as KEVEYIS, indicated for treatment of hyperkalemic periodic paralysis. The multiple award structure allows the Department of Veterans Affairs flexibility to distribute purchases among qualified contractors while leveraging Xeris' specialized pharmaceutical offerings to support clinical requirements and patient treatment protocols across the Veterans Integrated Service Network 12 footprint through the contract's five-year period of performance.
Quick answers
Who was awarded contract 36F79726D0087?
36F79726D0087 was awarded to Xeris Pharmaceuticals, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on April 1, 2026.
How much is contract 36F79726D0087 worth?
36F79726D0087's own ceiling is $44,862,427.
Who can order from contract 36F79726D0087?
36F79726D0087 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79726D0087 part of a contract vehicle?
Yes. 36F79726D0087 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79726D0087 competed?
The extent of competition for 36F79726D0087 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV